Insider Transactions in Q1 2023 at Mesa Laboratories Inc (MLAB)
Insider Transaction List (Q1 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 24
2023
|
John Sakys CFO |
SELL
Open market or private sale
|
Direct |
2,128
-9.89%
|
$355,376
$167.01 P/Share
|
Mar 24
2023
|
John Sakys CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,128
+8.99%
|
$185,136
$87.26 P/Share
|
Mar 22
2023
|
John Sakys CFO |
SELL
Open market or private sale
|
Direct |
2,500
-20.5%
|
$427,500
$171.62 P/Share
|
Mar 22
2023
|
John Sakys CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+17.01%
|
$305,000
$122.66 P/Share
|
Mar 15
2023
|
John Sakys CFO |
SELL
Open market or private sale
|
Direct |
1,000
-9.35%
|
$165,000
$165.71 P/Share
|
Mar 15
2023
|
John Sakys CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+8.55%
|
$70,000
$70.56 P/Share
|
Mar 09
2023
|
John Sakys CFO |
SELL
Open market or private sale
|
Direct |
400
-3.96%
|
$67,600
$169.97 P/Share
|
Mar 09
2023
|
John Sakys CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
400
+3.81%
|
$28,000
$70.56 P/Share
|
Feb 09
2023
|
John Sakys CFO |
SELL
Open market or private sale
|
Direct |
1,000
-9.35%
|
$184,000
$184.27 P/Share
|
Feb 09
2023
|
John Sakys CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+8.55%
|
$51,000
$51.85 P/Share
|
Feb 02
2023
|
John James Sullivan Director |
BUY
Bona fide gift
|
Indirect |
14,580
+24.65%
|
-
|
Feb 02
2023
|
John James Sullivan Director |
SELL
Bona fide gift
|
Direct |
14,580
-34.06%
|
-
|
Jan 23
2023
|
John Sakys CFO |
SELL
Open market or private sale
|
Direct |
2,100
-17.8%
|
$441,000
$210.19 P/Share
|
Jan 23
2023
|
John Sakys CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,100
+15.11%
|
$147,000
$70.56 P/Share
|
Jan 13
2023
|
John Bradley Schmieder Director |
SELL
Open market or private sale
|
Direct |
1,571
-2.23%
|
$300,061
$191.31 P/Share
|
Jan 13
2023
|
John Bradley Schmieder Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
571
+0.81%
|
$41,112
$72.02 P/Share
|